SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-027403
Filing Date
2018-11-06
Accepted
2018-11-06 16:07:33
Documents
3
Period of Report
2018-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR Q3 2018 EARNING RELEASE ctmx-8k_20181106.htm 8-K 32511
2 EX-99.1 ctmx-ex991_52.htm EX-99.1 319938
3 GRAPHIC grmaw453z1w5000001.jpg GRAPHIC 3735
  Complete submission text file 0001564590-18-027403.txt   358881
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 181163025
SIC: 2834 Pharmaceutical Preparations